Culverwell Anthony James bought QNRX

August 27, 2026 · Form 4 insider transaction

Culverwell Anthony James bought 31,352 shares of Quoin Pharmaceuticals, Ltd. at $5.15 per share, a transaction worth $161.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Acquired (buy-side)
Shares
31,352
Price
$5.15
Total value
$161.5K
Role
SecurityADSs
Transaction codeA: Grant or award
Transaction dateAugust 27, 2026
Filing dateAugust 28, 2026
Shares owned after34,218
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

Ordinary Shares are represented by American Depositary Shares ("ADSs"). Each ADS represents thirty-five (35) ordinary shares of the Issuer.; On August 27, 2026, the Issuer and the Reporting Person, entered into an exchange agreement, pursuant to which $161,461 of accrued interest outstanding ("Outstanding Debt") owed in connection with a note previously purchased by the Reporting Person was exchanged for 31,352 ADSs. The exchange agreement and the exchange of the Outstanding Debt for the ADSs was approved in advance by the Issuer's audit committee and board of directors.

View the original Form 4 on SEC EDGAR